2022
DOI: 10.1016/j.biopha.2022.113009
|View full text |Cite
|
Sign up to set email alerts
|

Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(22 citation statements)
references
References 117 publications
0
18
0
Order By: Relevance
“…Briefly, ExMVs can affect the proliferation and survival of leukemic cells, modulate the hematopoietic microenvironment to support leukemia cell expansion, contribute to immune escape by malignant cells, and promote chemotherapy resistance [ 12 , 24 27 , 30 , 31 ]. On the other hand, they could play a role in diagnosing hematopoietic malignancies as they express potential biomarkers and even be modified as drug carriers for therapy [ 22 , 32 34 ]. This will be discussed later in this review.…”
Section: Exmvs As Modulators Of Cell Functionmentioning
confidence: 99%
“…Briefly, ExMVs can affect the proliferation and survival of leukemic cells, modulate the hematopoietic microenvironment to support leukemia cell expansion, contribute to immune escape by malignant cells, and promote chemotherapy resistance [ 12 , 24 27 , 30 , 31 ]. On the other hand, they could play a role in diagnosing hematopoietic malignancies as they express potential biomarkers and even be modified as drug carriers for therapy [ 22 , 32 34 ]. This will be discussed later in this review.…”
Section: Exmvs As Modulators Of Cell Functionmentioning
confidence: 99%
“…AML is a group of aggressive hematopoietic malignancies that arise from myeloid precursors ( 149 ). Although AML treatments have improved significantly in recent decades, relapses of AML and drug resistance are still the major challenges in the treatment of AML ( 150 ), with only 40% of young patients staying in remission at five years after treatment ( 151 , 152 ). Therefore, more accurate classification and diagnosis are needed.…”
Section: The Roles Of Raman Spectroscopy In Pediatric Cancermentioning
confidence: 99%
“…It is characterized by incomplete maturation of myeloid cells that occurs due to the clonal over-proliferation of an aberrant stem cell engaged at the level of colony forming unit (CFU) or later stages of differentiation. This situation leads to the accumulation and clonal expansion of non-functional myeloblasts, known as blasts, that accumulate in the BM and blood [27]. AML induces multipotent mesenchymal stem/stromal cells (MSC) to differentiate into adipocytes rather than osteoblasts, with a metabolic shift from glycolysis to oxidative phosphorylation (OXPHOS) during energy production.…”
Section: Acute Myeloid Leukemiamentioning
confidence: 99%